146 related articles for article (PubMed ID: 13903841)
21. A speculative approach to the myeloproliferative syndromes.
BRODY JI; RODRIGUEZ F
Blood; 1962 May; 19():615-21. PubMed ID: 13873338
[No Abstract] [Full Text] [Related]
22. [Bone marrow fibrosis in malignant hemopathies and cancers. Histological study of 2 786 biopsies (author's transl)].
Duhamel G; Stachowiak J
Sem Hop; 1981 Jan 18-25; 57(3-4):111-6. PubMed ID: 6261348
[TBL] [Abstract][Full Text] [Related]
23. Serum lactic dehydrogenase activity in myeloproliferative and lymphoproliferative disorders.
Woodliff HJ; Lynch W
Med J Aust; 1967 Mar; 1(9):431-2. PubMed ID: 5336861
[No Abstract] [Full Text] [Related]
24. Chemicals most effective in malignant blood diseases.
SAMPEY JR
J S C Med Assoc; 1961 Apr; 57():163-4. PubMed ID: 13745959
[No Abstract] [Full Text] [Related]
25. [Reduced glutathione (GSH) in erythrocytes in myeloproliferative diseases].
Benöhr HC; Tigges FJ; Waller HD
Verh Dtsch Ges Inn Med; 1973; 79():461-3. PubMed ID: 4790261
[No Abstract] [Full Text] [Related]
26. [Jamshidi biopsy in clinical hematology. Method, indications and results of over 1,000 completed biopsies with special reference to chronic myeloproliferative diseases].
Seewann HL
Wien Med Wochenschr Suppl; 1986; 100():1-24. PubMed ID: 3471009
[TBL] [Abstract][Full Text] [Related]
27. [SERUM VITAMIN B 12 LEVELS IN CHRONIC MYELOPROLIFERATIVE DISORDERS].
SHIBATA A; TACHIBANA Y; TAKAHASHI Y; TAKASE S; YAMADA A; CHIBA R
Saishin Igaku; 1965 Jan; 20():173-6. PubMed ID: 14319001
[No Abstract] [Full Text] [Related]
28. Diagnostic and prognostic values of measurement of serum vitamin B12-binding proteins.
Herbert V
Blood; 1968 Aug; 32(2):305-12. PubMed ID: 4175078
[No Abstract] [Full Text] [Related]
29. [HEMATOLOGIC SYNDROMES CORRELATED WITH NEOPLASMS].
PIACENTINI G
Rass Clin Ter; 1964; 63():239-51. PubMed ID: 14204661
[No Abstract] [Full Text] [Related]
30. Serum vitamin B12 content and unsaturated vitamin B12-binding capacity in myeloproliferative disease. Value in differential diagnosis and as indicators of disease activity.
Gilbert HS; Krauss S; Pasternack B; Herbert V; Wasserman LR
Ann Intern Med; 1969 Oct; 71(4):719-29. PubMed ID: 5360286
[No Abstract] [Full Text] [Related]
31. [What is reliable in the therapy of hematologic diseases? II. Anemias, myeloproliferative diseases, panmyelopathy and agranulocytosis].
Sodomann CP; Malchow H; Schmidt M; Havemann K
Internist (Berl); 1970 Dec; 11(12):449-53. PubMed ID: 4924816
[No Abstract] [Full Text] [Related]
32. [Megakaryocytopoiesis in myeloproliferative disorders].
Podolak-Dawidziak M
Acta Haematol Pol; 1992; 23(2 Suppl 1):19-22. PubMed ID: 1488868
[No Abstract] [Full Text] [Related]
33. [THE SIGNIFICANCE OF ALKALINE LEUKOCYTE PHOSPHATASE FOR THE DIFFERENTIAL DIAGNOSIS AND PROGNOSIS OF MALIGNANT HEMOBLASTOSES].
SCHUMACHER K
Med Welt; 1964 Feb; 9():415-8. PubMed ID: 14152695
[No Abstract] [Full Text] [Related]
34. [COLLOID STORAGE IN THE BONE MARROW IN BLOOD DISEASES].
HOEFER R; OGRIS E; PFEIFFER G
Wien Z Inn Med; 1964 Aug; 45():330-5. PubMed ID: 14309552
[No Abstract] [Full Text] [Related]
35. [Activity of acid phosphatase in blood cells and bone marrow cells in some internal diseases].
Orzechowska-Juzwenko K; Kotlarek-Haus S; Brodzka W
Acta Haematol Pol; 1972; 3(3):229-35. PubMed ID: 4509821
[No Abstract] [Full Text] [Related]
36. [Nosological position of polycythemia vera in myeloproliferative syndromes].
SANCHEZ FAYOS J
Rev Clin Esp; 1957 Sep; 66(5):289-93. PubMed ID: 13527892
[No Abstract] [Full Text] [Related]
37. [On hyaluronidase activity of the blood in leukosis, lymphogranulomatosis and cancer].
KUKHTA VK
Vopr Onkol; 1961 Apr; 6():33-7. PubMed ID: 13754980
[No Abstract] [Full Text] [Related]
38. Diagnostic usefulness of acridine orange in fluorescence microscopy in certain hematological syndromes, particularly in proliferative processes.
Topolska P; Gürtler-Krawczyńska E
Pol Med J; 1968; 7(2):372-9. PubMed ID: 5241714
[No Abstract] [Full Text] [Related]
39. [Secondary hyperuricemia in hemoblastosis].
Richter R; Hermanny G; Hofer E; Stobbe H
Dtsch Gesundheitsw; 1971 Nov; 26(45):2126-30. PubMed ID: 5145658
[No Abstract] [Full Text] [Related]
40. Acute leukemia as a terminal event in nonleukemic hematopoietic disorders.
Bloomfield CD; Brunning RD
Semin Oncol; 1976 Sep; 3(3):297-317. PubMed ID: 790581
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
